SCOPUS 정보 검색 플랫폼

Volumn 22, Issue 12, 2000, Pages 1433-1442

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

(10) Miller, Paul D a Woodson, Grattan b Licata, Angelo A c Ettinger, Mark P d Mako, Barbara e Smith, Mary E e Wang, Lixia e Yates, John e Melton, Mary E e Palmisano, Joanne J e

a University of Colorado Health Sciences Center (United States)

b Atlanta Research Center (United States)

c LERNER RESEARCH INSTITUTE (United States)

d RADIANT RESEARCH (United States)

e MERCK RESEARCH LABORATORIES (United States)

Author keywords

Alendronate; Bisphosphonates; Osteoporosis; Upper gastrointestinal symptoms

Indexed keywords

ALENDRONIC ACID; CREATININE; PEPTIDE DERIVATIVE; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOPOROSIS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; VOMITING;

EID: 0034536509 PISSN: 01492918 EISSN: 1879114X Source Type: Journal
DOI: 10.1016/S0149-2918(00)83042-8 Document Type: Article

Times cited : (50)

References (11)

1
- 0034723772
- Upper gastrointestinal tract safety profile of alendronate: The Fracture Intervention Trial
- (2000) Arch Intern Med , vol.160 , pp. 517-525
- Bauer, D.C.¹ Black, D.² Ensrud, K.³

2
- 0031733852
- Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis
- (1998) Am J Manag Care , vol.4 , pp. 1377-1382
- Ettinger, B.¹ Pressman, A.² Schein, J.³

3
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
- (1995) N Engl J Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³

4
- 18244431006
- Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
- (1998) N Engl J Med , vol.339 , pp. 292-299
- Saag, K.G.¹ Emkey, R.² Schnitzer, T.J.³

5
- 85031537738
- Alendronate for treatment of osteoporosis in elderly female long term care facility (LTCF) residents
- May 19-23, Philadelphia, Pa
- (1999) Annual Meeting of the American Geriatrics Society/American Federation on Aging Research
- Greenspan, S.L.¹ Bonin, R.² DeLucca, P.³

6
- 0030931230
- Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
- (1997) Gastroenterology , vol.112 , pp. 1448-1456
- Locke III, G.R.¹ Talley, N.J.² Fett, S.L.³

7
- 0003575316
- Estimation of survival probability
- Analysing Survival Data from Clinical Trials and Observational Studies. 1st ed. Chichester, NY: John Wiley & Sons
- (1995) , pp. 57-63
- Marubini, E.¹ Valsecchi, M.G.² Emmerson, M.³

8
- 0032467224
- Crosslinked N-telopeptides of bone collagen: A marker of bone resorption
- (1998) J Clin Ligand Assay , vol.21 , pp. 111-117
- Mallinak, N.J.S.¹ Clemens, J.D.²

9
- 0030816322
- Summary of safety profile and future research with alendronate
- (1997) Br J Rheumatol. , vol.36 , Issue.SUPPL. 1 , pp. 20-23
- Daifotis, A.G.¹ Karpf, D.B.²

10
- 0029383187
- An overview of the results of clinical trials with alendronate, a promising treatment of osteoporosis in postmenopausal women
- (1995) Ann Ital Med Int. , vol.10 , Issue.SUPPL.
- Hirsch, L.J.¹ Pryor-Tillotson, S.²

11
- 0004851872
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- (1996) Lancet , vol.348 , pp. 1535-1541
- Black, D.M.¹ Cummings, S.R.² Karpf, D.B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.